D. E. Shaw & Co., Inc. Pardes Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.84 - $8.57 $84,629 - $255,377	29,799 Added 109.26%	57,072 $175,000
Q1 2022 May 16, 2022	SELL	$5.64 - $15.64 $60,720 - $168,380	-10,766 Reduced 28.3%	27,273 $197,000
Q4 2021 Feb 14, 2022	BUY	$9.8 - $17.02 $372,782 - $647,423	38,039 New	38,039 $623,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.